TLC399 (ProDex)

ProDex · Taiwan Liposome Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLC399 (ProDex), covering 2021-12-23 to 2021-12-23. Get the full timeline:

Most recent: Clinical Trial Update: TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 2]